HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study
Open Access
- 10 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 26 (4) , 287-292
Abstract
Objective: The purpose of this study was to assess if cytology can be omitted in the follow-up after treatment for cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and if human papillomavirus (HPV) test can be used alone as test of cure (TOC) after stratifying for resection margins. Material and Methods: In this retrospective register-based study, women who had a conization performed in Denmark between January 1 and December 31, 2013, were included. Histology, cytology, and HPV test results were obtained from The Danish Pathology Data Bank for a 3-year follow-up. Results: A total of 5,174 women were included, of whom 6.1% (318/5,174) had histological residual/recurrent disease in the follow-up period. In the group with free margins, 2.6% (73/2,780) had residual/recurrent disease in contrast to 10.2% (245/2,394) in the group with involved margins. In the group with free resection margins and negative HPV test results, residual/recurrent disease was found in 0.5% (13/2,780) compared with 0.3% (9/2,780) in the group with negative HPV test results and normal cytology at 6 months′ follow-up. Based on margin status and HPV test result as follow-up, the sensitivity, specificity, and positive and negative predictive values were 95.9%, 43.2%, 10.0%, and 99.4% respectively, and for combined testing (margin status, HPV, and cytology), 97.2%, 41.2%, 9.8%, and 99.6%, respectively. Conclusions: Using the HPV test at the first post-treatment control as TOC for cervical intraepithelial neoplasia grade 2 or worse after stratifying for resection margins in cone resections yields an equally high sensitivity and negative predictive value as cotesting with cytology. We suggest that women with free resection margins return to the routine screening program after negative HPV test result as TOC at 6 months.Keywords
This publication has 22 references indexed in Scilit:
- Role of human papillomavirus testing and cytology in follow‐up after conizationActa Obstetricia et Gynecologica Scandinavica, 2015
- Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortalityBMJ, 2014
- Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AISJournal of Lower Genital Tract Disease, 2013
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical CancerVaccine, 2012
- High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: A systematic review and meta-analysisGynecologic Oncology, 2012
- Early human papillomavirus testing predicts residual/recurrent disease after LEEPJournal of Gynecologic Oncology, 2012
- Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort studyThe Lancet Oncology, 2011
- Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data BankClinical Epidemiology, 2010
- Does HPV-status 6–12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?European Journal of Cancer, 2007
- Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasiaInternational Journal of Gynecological Cancer, 2006